Anika to Participate in Two Investor Events in May 2019
BEDFORD, Mass.--(BUSINESS WIRE)--May 6, 2019--Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today announced that the Company will participate in the following two investor events in May:
- Deutsche Bank 44 th Annual Health Care Conference on Tuesday, May 7, 2019 at The InterContinental Hotel in Boston.
- Singular Research Spring Select Web Call on Thursday, May 30, 2019.
A live audio webcast of the Singular Research Spring Select Web Call may be accessed via the ″Investor Relations″ section of Anika’s website at www.anikatherapeutics.com. An audio archive of the presentation also will be available on the website.
About Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (NASDAQ: ANIK) is a global, integrated orthopedic and regenerative medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative tissue repair. The Company has over two decades of global expertise developing, manufacturing, and commercializing more than 20 products based on its proprietary hyaluronic acid (HA) technology. Anika’s orthopedic medicine portfolio includes ORTHOVISC®, MONOVISC®, and CINGAL®, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration. For more information about Anika, please visit www.anikatherapeutics.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190506005365/en/
CONTACT: For Investor Inquiries:
Anika Therapeutics, Inc.
Sylvia Cheung, 781-457-9000
Chief Financial Officer
For Media Inquiries:
Sonal Vasudev, 917-523-1418
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL OTHER HEALTH
SOURCE: Anika Therapeutics, Inc.
Copyright Business Wire 2019.
PUB: 05/06/2019 08:30 AM/DISC: 05/06/2019 08:30 AM